1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要業界動向
5 世界の輸液市場
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 タイプ別市場構成
5.5 栄養素別市場構成比
5.6 地域別市場構成
5.7 市場予測
5.8 SWOT分析
5.8.1 概要
5.8.2 強み
5.8.3 弱点
5.8.4 機会
5.8.5 脅威
5.9 バリューチェーン分析
5.9.1 概要
5.9.2 研究開発
5.9.3 原材料調達
5.9.4 製造
5.9.5 マーケティング
5.9.6 流通
5.9.7 最終用途
5.10 ポーターズファイブフォース分析
5.10.1 概要
5.10.2 買い手の交渉力
5.10.3 供給者の交渉力
5.10.4 競争の程度
5.10.5 新規参入の脅威
5.10.6 代替品の脅威
6 タイプ別市場
6.1 部分非経口栄養
6.1.1 市場動向
6.1.2 市場予測
6.2 全体非経口栄養剤
6.2.1 市場動向
6.2.2 市場予測
7 栄養素別市場内訳
7.1 炭水化物
7.1.1 市場動向
7.1.2 市場予測
7.2 塩分・電解質
7.2.1 市場動向
7.2.2 市場予測
7.3 ミネラル
7.3.1 市場動向
7.3.2 市場予測
7.4 ビタミン
7.4.1 市場動向
7.4.2 市場予測
7.5 アミノ酸
7.5.1 市場動向
7.5.2 市場予測
8 地域別市場内訳
8.1 北米
8.1.1 市場動向
8.1.2 市場予測
8.2 欧州
8.2.1 市場動向
8.2.2 市場予測
8.3 アジア太平洋
8.3.1 市場動向
8.3.2 市場予測
8.4 中東・アフリカ
8.4.1 市場動向
8.4.2 市場予測
8.5 中南米
8.5.1 市場動向
8.5.2 市場予測
9 静注液の製造工程
9.1 製品概要
9.2 原材料要件
9.3 製造プロセス
9.4 主な成功要因とリスク要因
10 競争環境
10.1 市場構造
10.2 主要プレーヤー
10.3 主要プレーヤーのプロフィール
10.3.1 味の素
10.3.1.1 会社概要
10.3.1.2 概要
10.3.1.3 製品ポートフォリオ
10.3.1.4 財務
10.3.1.5 SWOT分析
10.3.2 B. ブラウンメルスンゲン
10.3.2.1 会社概要
10.3.2.2 概要
10.3.2.3 製品ポートフォリオ
10.3.2.4 財務
10.3.2.5 SWOT分析
10.3.3 バクスターインターナショナルインク
10.3.3.1 会社概要
10.3.3.2 概要
10.3.3.3 製品ポートフォリオ
10.3.3.4 財務
10.3.3.5 SWOT分析
10.3.4 グリフォルス
10.3.4.1 会社概要
10.3.4.2 概要
10.3.4.3 製品ポートフォリオ
10.3.4.4 財務
10.3.4.5 SWOT分析
10.3.5 大塚製薬
10.3.5.1 会社概要
10.3.5.2 概要
10.3.5.3 製品ポートフォリオ
図1：世界：輸液市場：主な推進要因と課題
図2：世界：点滴ソリューション市場：販売額（単位：億米ドル）、2019年～2024年
図3：世界：点滴ソリューション市場：タイプ別内訳（単位：%）、2024年
図4：点滴液の世界市場：タイプ別構成比（単位：%）、2024年図4：点滴液の世界市場：栄養素別構成比（%）、2024年
図5：輸液の世界市場：栄養剤別構成比（%）、2024年点滴液の世界市場：地域別構成比（%）、2024年
図6：輸液の世界市場予測：販売額（単位：億米ドル）、2025年～2033年
図7：世界の輸液産業：SWOT分析
図8: 世界の点滴ソリューション産業:SWOT分析バリューチェーン分析
図9: 世界: 静脈内ソリューション産業：ポーターのファイブフォース分析
図10：世界：静脈内ソリューション（部分非経口栄養）市場：販売額（単位：百万米ドル）、2019年および2024年
図11：世界：点滴ソリューション（部分非経口栄養）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図12：輸液（全身非経口栄養）の世界市場：売上額（単位：百万ドル販売額（単位：百万米ドル）、2019年および2024年
図13：輸液（総合非経口栄養剤）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図14：輸液（炭水化物）の世界市場：販売額（単位：百万米ドル販売額（単位：百万米ドル）、2019年・2024年
図15：輸液（炭水化物）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図16：世界の輸液（塩類・電解質）市場：販売額（単位：百万米ドル）、2019年および2024年
図17：世界の輸液（塩類・電解質）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図18：世界の輸液（ミネラル）市場：販売額（単位：百万米ドル）、2019年・2024年
図19：輸液（ミネラル）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図20：点滴静注液（ビタミン）の世界市場販売額（単位：百万米ドル）、2019年・2024年
図21：輸液（ビタミン剤）の世界市場予測：販売額（百万ドル）、2025年～2033年
図22：輸液（アミノ酸）の世界市場：販売額（単位：百万米ドル販売額（単位：百万米ドル）、2019年・2024年
図23：輸液（アミノ酸）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図24: 北米: 点滴液市場：販売額（単位：百万米ドル）、2019年および2024年
図25：北米：輸液市場予測：販売額（単位：百万米ドル）、2025年～2033年
図26：ヨーロッパ：点滴液市場：販売額（単位：百万米ドル）、2019年および2024年
図27：欧州：点滴液市場予測：販売額（単位：百万米ドル）、2025年～2033年
図28：アジア太平洋地域：輸液市場：販売額（単位：百万米ドル）、2019年および2024年
図29：アジア太平洋地域：輸液市場予測：販売額（単位：百万米ドル）、2025年～2033年
図30：中東・アフリカ：輸液市場：販売額（単位：百万米ドル）、2019年および2024年
図31：中東・アフリカ：点滴ソリューション市場予測：販売額（単位：百万米ドル）、2025年～2033年
図32：中南米：点滴ソリューション市場：販売額（単位：百万米ドル）、2019年および2024年
図33：ラテンアメリカ：点滴ソリューション市場予測：販売額（単位：百万米ドル）、2025年～2033年
図34：輸液の製造：詳細なプロセスフロー
[表一覧］
表1：世界：輸液市場：主要産業ハイライト、2024年および2033年
表2：世界：点滴液市場予測：タイプ別内訳（単位：百万米ドル）、2025年〜2033年
表3：点滴液の世界市場予測：タイプ別内訳（単位：百万ドル）、2025年～2033年栄養成分別構成比（単位：百万米ドル）、2025-2033年
表4：点滴液の世界市場予測：地域別構成比（単位：百万米ドル）、2025-2033年
表5：輸液：原材料所要量
表6：輸液の世界市場：競合構造競合構造
表7：点滴ソリューションの世界市場：競合構造主要プレーヤー
The global intravenous solutions market size was valued at USD 15.6 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 23.3 Billion by 2033, exhibiting a CAGR of 4.53% from 2025-2033. North America currently dominates the market, holding a market share of over 40.7% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, rising chronic disease prevalence, and increasing elderly population.
Intravenous (IV) solutions refer to sterile liquids used to administer fluids directly into a patient's bloodstream. It includes isotonic, hypertonic, and hypotonic solutions, catering to different medical needs. They are produced using various ingredients, such as water, electrolytes, sugars, vitamins, and medications. IV solutions are widely used in hydration therapy, nutritional support, medication delivery, blood transfusion, chemotherapy, pain management, correcting electrolyte imbalances, and detoxification treatments. They offer several benefits, such as controlled administration, reduced digestive system impact, tailored nutrient delivery, direct bloodstream access, and enhanced recovery support.
The rapid expansion of healthcare facilities, such as hospitals, clinics, and specialized care centers, which are generating more opportunities for IV treatments, is propelling the market growth. Additionally, the imposition of supportive policies by governments and regulatory bodies to ensure the availability of high-quality intravenous solutions across healthcare facilities is positively influencing the market growth. Furthermore, the growing demand for IV solutions in emergency scenarios and surgical procedures is contributing to the market growth. Apart from this, the increasing shift towards home healthcare, where patients receive treatment in their own homes, is facilitating the demand for specialized IV solutions. Besides this, the rising product application in treating a large number of patients quickly during global health emergencies, such as pandemics, is catalyzing the market growth.
Intravenous Solutions Market Trends/Drivers:
The increasing prevalence of disease
The heightened prevalence of chronic diseases, such as diabetes, cardiovascular ailments, cancer, and acute conditions, which necessitate IV treatments, is a prominent factor propelling the market growth. Furthermore, emerging global trends, such as lifestyle changes, environmental factors, and genetic predispositions, which lead to an increase in chronic conditions, are acting as another growth-inducing factor. Additionally, several chronic and acute illnesses require direct administration of fluids, nutrients, or medications into the bloodstream. In line with this, IV solutions facilitate precise delivery of essential nutrients and medication and ensure quick patient recovery. In addition, they also enable faster, more controlled care, particularly in critical situations.
The rising geriatric population
The rising geriatric population is contributing significantly to the growth of the IV solutions market. The high susceptibility of the aging population to various health issues and chronic conditions, which often require complex medical interventions, including IV therapy, is propelling the market growth. Furthermore, the presence of a weaker immune system, reduced organ functionality, and other age-related physiological changes that make geriatric individuals more prone to infections and diseases are facilitating the market growth. In line with this, IV solutions are vital in providing essential hydration, nutrients, and medications, ensuring that the treatments are targeted and efficient. Moreover, the widespread utilization of IV solutions to restore imbalance in electrolytes, such as sodium, potassium, calcium, and magnesium, is acting as another growth-inducing factor.
The rapid technological advancements
Technological advancements in medical care and the production of IV solutions are contributing to the market growth. In line with this, new technologies are enabling the formulation of more specialized solutions, catering to specific patient needs, and enhancing the efficiency and safety of IV therapies. Furthermore, the recent innovations in infusion pumps and delivery systems, which allow healthcare providers to administer treatments with greater precision and control, are positively influencing the market growth. Additionally, technological breakthroughs in monitoring and managing IV therapies to lower the risk of complications and improve patient outcomes are acting as another growth-inducing factor. Moreover, extensive research and development (R&D) efforts focusing on biocompatibility, personalized treatment plans, and integrating technology, such as artificial intelligence (AI), to augment care are supporting the market growth.
Intravenous Solutions Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global intravenous solutions market report, along with forecasts at the global and regional levels from 2025-2033. Our report has categorized the market based on type and nutrients.
Breakup by Type:
• Partial Parenteral Nutrition
• Total Parenteral Nutrition
Total parenteral nutrition dominates the market
The report has provided a detailed breakup and analysis of the market based on type. This includes partial parenteral nutrition and total parenteral nutrition. According to the report, total parenteral nutrition represented the largest segment.
Total parenteral nutrition (TPN) is dominating the market as it is used to fulfill all the nutritional requirements of patients who cannot eat or absorb enough food through regular digestive means. Additionally, it finds extensive applications across various medical fields, including oncology, gastroenterology, and intensive care units (ICUs). Furthermore, the rising number of chronic conditions, such as cancer and gastrointestinal diseases, that necessitate the use of TPN for nutritional support is propelling the market growth. Apart from this, increasing utilization of TPN to meet the nutritional needs of patients undergoing major surgical procedures is catalyzing the market growth. Moreover, the recent improvements in TPN formulation and administration technology, ensuring safer and more personalized nutrition support, are strengthening the market growth.
Breakup by Nutrients:
• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins
• Amino Acids
A detailed breakup and analysis of the market based on the nutrients has also been provided in the report. This includes carbohydrates, salts and electrolytes, minerals, vitamins, and amino acids.
Carbohydrates serve as a primary energy source for the human body. They are essential in providing immediate energy, particularly for patients unable to consume food orally. In addition, they are used by all cells in the body, which makes them suitable for a diverse range of patients, irrespective of their specific conditions. Furthermore, carbohydrates can be easily administered through IV solutions, allowing for controlled delivery.
Minerals, such as magnesium, calcium, potassium, and sodium, play critical roles in maintaining various bodily functions, including muscle contraction, nerve transmission, and maintaining fluid balance. Furthermore, IV solutions with specific mineral compositions are essential in correcting electrolyte imbalance, restoring normal cellular function, and stabilizing the patient. Apart from this, minerals are utilized in various medical scenarios, from emergency care to post-operative recovery and chronic disease management.
Breakup by Region:
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
North America exhibits a clear dominance, accounting for the largest intravenous solutions market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.
North America hosts one of the world's most advanced healthcare systems comprising state-of-the-art medical facilities equipped with cutting-edge technology that is fostering a conducive environment for the utilization of IV solutions. Additionally, the region's healthcare spending is among the highest globally, enabling greater access to quality medical care, including treatments requiring intravenous solutions. Furthermore, the implementation of a comprehensive regulatory framework by the regional governments to ensure that IV solutions meet strict quality and safety standards is boosting the market growth. Apart from this, the high prevalence of chronic conditions like diabetes, heart disease, and cancer, which necessitates regular medical interventions, is acting as another growth-inducing factor. Besides this, North America has a strong network of universities, research institutions, and pharmaceutical companies that are actively investing in developing new intravenous solutions and improving existing ones.
Competitive Landscape:
The major players are focusing on creating advanced intravenous products, such as the formulation of new solutions with improved efficiency, the integration of innovative technologies like smart infusion pumps, and the development of personalized therapies. In addition, they are expanding their reach into these regions by setting up new manufacturing facilities, partnering with local distributors, and adapting products to meet specific regional needs. Furthermore, leading companies are engaging in mergers and acquisitions to diversify their product portfolios, leverage synergies, and expand their geographical presence. Moreover, they are placing strong emphasis on quality control and regulatory compliance to ensure that their products meet all relevant safety and efficacy standards. Besides this, top companies in the IV solutions market are focusing on environmentally responsible manufacturing processes and materials by reducing waste and energy consumption and using sustainable resources.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
• Ajinomoto Co., Inc.
• B. Braun Melsungen AG
• Baxter International, Inc.
• Grifols S.A.
• Otsuka Pharmaceutical.
Key Questions Answered in This Report
1.What are intravenous solutions?
2.How big is the global intravenous solutions market?
3.
What is the expected growth rate of the global intravenous solutions market during 2025-2033?
4.What are the key factors driving the global intravenous solutions market?
5.What is the leading segment of the global intravenous solutions market based on type?
6.What is the leading segment of the global intravenous solutions market based on nutrients?
7.What are the key regions in the global intravenous solutions market?
8.Who are the key players/companies in the global intravenous solutions market?
